Fate Therapeutics FATE Balance Sheet (2012-2026)

NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Fate Therapeutics Quarterly Balance Sheet

Periods 57 quarters
Latest Sep 2026

Fate Therapeutics reported total assets of $0.24B and total liabilities of $0.11B for the quarter ended Sep 2026, down 30.7% year over year. This balance sheet covers 57 quarters of results from Sep 2012 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
133.58M64.74M55.28M82.09M61.33M42.02M46.80M33.33M41.87M121.32M36.92M37.91M36.06M44.92M41.25M40.62M46.63M39.57M32.43M43.94M
Short-term InvestmentsInvestments (Current)
482.33M509.03M513.58M423.04M374.89M366.88M331.13M316.40M273.31M262.22M267.96M259.01M243.01M195.51M181.58M174.80M157.03M135.25M121.34M95.19M
Cash & Current Investments
615.91M573.77M568.85M505.14M436.23M408.90M377.94M349.73M315.18M383.54M304.88M296.92M279.07M240.43M222.83M215.42M203.66M174.80M153.80M139.10M
Receivables - NetNet Receivables
8.68M13.85M13.13M10.22M38.48M13.50M2.83M1.54M1.83M0.86M1.05M4.13M3.54M2.41M1.40M0.68M0.92M0.70M0.70M0.48M
Receivables
8.68M13.85M13.13M10.22M38.48M13.50M2.83M1.54M1.83M0.86M1.05M4.13M3.54M2.41M1.40M0.68M0.92M0.70M0.70M0.48M
Current Deferred Tax AssetsCurrent Deferred Tax
35.39M49.74M55.49M63.13M66.65M
Prepaid Assets
8.83M11.45M17.18M19.97M27.37M15.49M11.41M12.90M14.54M9.97M13.46M9.24M9.30M5.39M6.17M5.15M4.13M4.00M3.48M4.65M
Current Assets
633.41M599.08M599.16M535.33M502.07M437.89M392.18M364.17M331.54M394.38M319.39M310.29M291.91M248.22M230.40M221.25M208.70M179.53M157.95M144.26M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
91.53M97.86M103.12M109.12M110.02M108.59M106.33M101.71M96.84M92.12M87.53M82.39M64.38M62.76M61.10M59.48M56.93M54.26M51.55M48.91M
Long-Term Investments
100.66M67.94M11.93M13.94M4.94M3.91M7.29M0.98M7.60M47.16M33.61M27.66M32.29M26.10M10.31M1.47M
Goodwill
2,761.11M288.41M261.36M2,755.09M0.00M179.71M153.44M2,755.09M
Goodwill & Intangibles
6.99M8.01M9.22M2,761.11M8.69M288.41M261.36M2,755.09M8.00M179.71M153.44M2,755.09M
Other Non-Current Assets
15.26M15.26M15.26M15.26M15.26M15.26M15.21M15.19M15.19M15.19M15.19M10.24M10.24M10.23M10.23M10.23M10.23M10.05M10.05M5.10M
Non-Current Assets
288.04M259.31M207.90M214.02M203.49M192.45M192.58M179.61M174.68M175.52M209.43M184.68M148.79M150.45M141.24M122.42M110.23M105.39M102.15M94.02M
Assets
921.46M858.39M807.06M749.35M705.56M630.34M584.76M543.79M506.22M569.89M528.82M494.97M440.69M398.67M371.63M343.67M318.94M284.92M260.10M238.28M
Liabilities
Current Liabilities
Accounts Payables
8.61M11.44M8.42M9.59M8.27M9.86M7.51M5.71M4.72M6.77M5.50M6.35M9.37M4.19M4.04M3.50M2.66M3.28M3.26M2.93M
Notes Payables
Payables
8.61M11.44M8.42M9.59M8.27M9.86M7.51M5.71M4.72M6.77M5.50M6.35M9.37M4.19M4.04M3.50M2.66M3.28M3.26M2.93M
Accumulated Expenses
42.41M35.11M40.52M50.15M53.93M31.51M29.47M28.54M27.51M32.04M22.65M23.58M21.35M17.21M18.18M17.57M20.02M13.64M14.90M15.15M
Other Accumulated Expenses
11.71M13.03M12.29M18.90M19.18M10.23M8.11M8.63M8.12M18.65M8.01M10.50M6.36M6.77M4.87M3.86M4.41M3.96M3.28M4.71M
Short term Debt
Current Taxes
Current Deferred Revenue
21.48M22.58M33.66M35.24M42.23M1.74M1.93M1.11M0.69M0.16M0.60M0.39M0.21M0.01M0.38M0.58M
Current Deferred Tax LiabilityCurrent Deferred Tax
-226.78M-296.25M-323.96M362.08M387.97M
Total Current Liabilities
81.28M77.91M91.52M103.94M114.05M48.65M44.69M41.33M39.09M45.37M34.79M37.42M38.52M28.16M28.67M28.11M36.07M30.69M32.59M32.69M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Non-Current Deferred Revenue
27.12M22.53M17.74M12.41M1.93M1.11M0.69M0.16M0.60M0.39M0.21M0.01M0.38M0.58M
Pension
12.90M12.90M12.90M
Preferred Stock Liabilities
13,775.43M13,775.43M13,775.43M13,775.43M13,775.43M13,775.43M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
-22.17M-20.69M-18.67M-12.01M-11.36M
Operating Leases
109.24M107.94M106.59M105.16M103.71M102.07M100.56M98.98M97.36M95.67M93.92M92.09M77.85M76.79M75.68M74.49M73.29M72.05M70.75M69.38M
Other Non-Current Liabilities
24.17M15.81M9.93M9.04M3.86M2.14M1.75M0.70M1.35M2.74M1.18M1.20M0.53M0.25M0.32M0.41M0.28M0.36M0.94M0.79M
Total Non-Current Liabilities
218.45M209.18M216.65M222.31M217.76M150.72M145.25M140.31M136.45M141.04M130.65M131.45M121.44M110.01M109.95M109.20M111.47M104.85M105.72M104.45M
Total Liabilities
242.62M224.99M226.58M231.35M221.62M152.86M147.00M141.01M137.80M143.78M131.84M132.64M121.97M110.26M110.27M109.61M111.75M105.21M106.67M105.24M
Shareholder's Equity
Total Debt
Common Equity
678.84M633.39M580.48M518.00M483.94M477.47M437.76M402.78M368.42M426.12M396.98M362.33M318.73M288.41M261.36M234.07M207.18M179.71M153.44M133.03M
Liabilities and Shareholders Equity
921.46M858.39M807.06M749.35M705.56M630.34M584.76M543.79M506.22M569.89M528.82M494.97M440.69M398.67M371.63M343.67M318.94M284.92M260.10M238.28M
Retained Earnings
-769.08M-834.77M-910.88M-994.44M-1,050.80M-1,069.69M-1,122.44M-1,167.61M-1,211.73M-1,259.74M-1,298.16M-1,345.84M-1,397.99M-1,435.62M-1,469.69M-1,501.94M-1,534.31M-1,600.00M-1,600.00M-1,626.37M
Preferred Shares
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M

Fate Therapeutics Balance Sheet API

Pull Fate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=FATE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY